Brief: U.S. Partial Clinical Hold On Diamyd® Phase Iii Trial Lifted By The FDA

Diamyd Medical AB

26/11/2022 12:24

Nov 26 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * US PARTIAL CLINICAL HOLD ON DIAMYD® PHASE III TRIAL LIFTED
BY
THE FDA
    * DIAMYD MEDICAL AB  DMYDb.ST  - FOLLOWING DECISION FROM
FDA,
DIAGNODE-3 IS APPROVED TO START IN US

Source text for Eikon:  ID:nWkr1FWp8F 
Further company coverage:  DMYDb.ST 
 ((Reuters.Briefs@thomsonreuters.com;))